|
|
|
|
|
|
|
|
|
|
Areas covered in this review:
A systematic literature review of clinical studies published between January 2005 and March 2010 was conducted using search engines, PubMed and MEDLINE with the entry keywords ‘ovarian cancer’ and ‘platinum resistance’. This search revealed 40 clinical trials (1793 patients).
Take home message:
Analysis of recent clinical trials showed that gemcitabine-based combination chemotherapy was associated with the highest antitumor effects in platinum-resistant ovarian cancer patients during the study period.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.